»N2B-Patch« – Nose-To-Brain Delivery of an Active
Pharmaceutical Ingredient via the Olfactory Region

Carmen Gruber Traub; Jenny Ullrich

Email Us: info@lupinepublishers.com phone

Call Us: +1 (914) 407-6109 57 West 57th Street, 3rd floor, New York - NY 10019, USA

Submit Manuscript

ISSN: 2637-4706

Drug Designing & Intellectual Properties International Journal

Short Communication(ISSN: 2637-4706)

»N2B-Patch« – Nose-To-Brain Delivery of an Active Pharmaceutical Ingredient via the Olfactory Region

Volume 1 - Issue 4

**Carmen Gruber Traub* and Jenny Ullrich**

Author Information Open or Close
- Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany
*Corresponding author: Carmen Gruber Traub, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Nobelstrasse 12, 70569 Stuttgart, Germany

Received: May 04, 2018; Published: May 10, 2018

DOI: 10.32474/DDIPIJ.2018.01.000116

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Within the EU funded project »N2B-patch« eleven partners from eight countries aim to develop an innovative technology for the nose-to-brain delivery of an active pharmaceutical ingredient via the olfactory region for the regenerative treatment of multiple sclerosis using novel multi-functional biomaterials combined with a medical device. The four year EU-funded research involves an innovative method of bypassing the blood-brain barrier by delivering a potential multiple sclerosis drug with a special medical device via the nose directly to the brain.

Keywords: nose-to-brain, multiple sclerosis, multi-functional biomaterial, drug delivery, API-loaded particles

Abstract| Short Communication| Acknowledgement| Refernces|

Editorial Manager:

Christine Timothy

Email:

drug@lupinepublishers.com

drug@lupinepublisher.co

Track Your Article

Top Editors

Mark E Smith

Bio chemistry
University of Texas Medical Branch, USA
Lawrence A Presley

Department of Criminal Justice
Liberty University, USA
Thomas W Miller

Department of Psychiatry
University of Kentucky, USA
Gjumrakch Aliev

Department of Medicine
Gally International Biomedical Research & Consulting LLC, USA
Christopher Bryant

Department of Urbanisation and Agricultural
Montreal university, USA
Robert William Frare

Oral & Maxillofacial Pathology
New York University, USA
Rudolph Modesto Navari

Gastroenterology and Hepatology
University of Alabama, UK
Andrew Hague

Department of Medicine
Universities of Bradford, UK
George Gregory Buttigieg

Maltese College of Obstetrics and Gynaecology, Europe
Chen-Hsiung Yeh

Oncology
Circulogene Theranostics, England
Emilio Bucio-Carrillo

Radiation Chemistry
National University of Mexico, USA
Casey J Grenier

Analytical Chemistry
Wentworth Institute of Technology, USA
Hany Atalah

Minimally Invasive Surgery
Mercer University school of Medicine, USA
Abu-Hussein Muhamad

Pediatric Dentistry
University of Athens , Greece